Co-Diagnostics, Inc. Net Income Loss

Quick Answer

Co-Diagnostics, Inc. reported Net Income Loss of -$46.90 million for the year ending 2025.

  • Co-Diagnostics, Inc. showed a decrease of -24.6% in Net Income Loss from 2024 to 2025.
  • This data is from Co-Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), Co-Diagnostics, Inc.'s Net Income Loss has declined by 2,331.5%.
  • Historical annual values: Fiscal year 2025: -$46.90 million | Fiscal year 2024: -$37.64 million | Fiscal year 2023: -$35.33 million | Fiscal year 2022: -$14.24 million | Fiscal year 2021: $36.66 million | Fiscal year 2020: $42.48 million | Fiscal year 2019: -$6.20 million | Fiscal year 2018: -$6.27 million | Fiscal year 2017: -$6.96 million | Fiscal year 2016: -$1.93 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: